_1777370193195_831968492.png&w=48&q=75){kind=small}
Johnson & Johnson Reaches Deal with Sail Biomedicines
Johnson & Johnson has agreed to make initial payments of $785 million and holds an exclusive option to acquire Sail for $2.58 billion.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading